Dr. Julie Larkin, MD
What this data tells you about Dr. Larkin
Dr. Julie Larkin is an infectious disease in Sarasota, FL, with 19 years in practice. Based on federal Medicare data, Dr. Larkin performed 248,253 Medicare services across 2,535 unique beneficiaries.
Between the years covered by Open Payments, Dr. Larkin received a total of $489 from 4 pharmaceutical and/or device companies across 9 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Larkin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Daptomycin antibiotic injection | 221,400 | $0 | $1 |
| Injection, dalbavancin, 5 mg | 17,100 | $12 | $31 |
| Ceftriaxone antibiotic injection | 3,232 | $0 | $35 |
| Hospital follow-up visit, high complexity | 1,117 | $96 | $295 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 1,093 | $49 | $225 |
| Infusion, normal saline solution, 250 cc | 1,010 | $1 | $15 |
| Injection, cefepime hydrochloride, 500 mg | 736 | $1 | $42 |
| Injection, ertapenem sodium, 500 mg | 570 | $11 | $78 |
| Hospital follow-up visit, moderate complexity | 369 | $64 | $265 |
| Office visit, established patient (30-39 min) | 351 | $95 | $384 |
| Office visit, established patient (20-29 min) | 217 | $67 | $273 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 186 | $22 | $95 |
| Refilling and maintenance of portable pump | 160 | $97 | $375 |
| Office visit, established patient, complex (40-54 min) | 150 | $135 | $544 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 111 | $55 | $125 |
| Blood draw (venipuncture) | 72 | $8 | $20 |
| Transitional care management services for problem of at least moderate complexity | 64 | $161 | $375 |
| New patient office visit, complex (60-74 min) | 60 | $170 | $670 |
| Transitional care management services for problem of high complexity | 55 | $200 | $450 |
| Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 53 | $122 | $250 |
| Nursing facility visit, moderate complexity | 46 | $85 | $170 |
| 5% dextrose/water (500 ml = 1 unit) | 40 | $1 | $15 |
| New patient office visit (45-59 min) | 27 | $123 | $507 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 22 | $41 | $85 |
| Initial hospital admission, high complexity | 12 | $140 | $375 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (55%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in infectious disease and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Larkin is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), and speaking/promotional industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Larkin experienced with daptomycin antibiotic injection?
Does Dr. Larkin receive payments from pharmaceutical companies?
How do Dr. Larkin's costs compare to other infectious diseases in Sarasota?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology